Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
Nefropatía membranosa muy tardía secundaria a alemtuzumab en paciente con esclerosis múltiple
Área salud
Impact of COVID-19 on physiotherapy for patients with multiple sclerosis in Spain: Adaptation and challenges in the implementation of telerehabilitation
Introduction The COVID-19 pandemic, declared in March 2020, had a profound impact on health services in Spain, especially on physiotherapy for people with multiple sclerosis (PwMS). The health reorganization forced the suspension of rehabilitation services, […]
Área salud
Riesgo de cáncer cutáneo asociado a terapias modificadoras de la enfermedad en la esclerosis múltiple: revisión narrativa de la evidencia actual
Los fármacos modificadores de la esclerosis múltiple (FAME) han supuesto un cambio en el manejo de esta enfermedad. Algunos estudios sugieren un incremento en la incidencia de cáncer cutáneo (CC) asociado a estos medicamentos. Mediante […]
Área salud
Multiple sclerosis: A descriptive series
Introduction Multiple sclerosis (MS) is a chronic multifocal inflammatory demyelinating disease that progresses with neurodegeneration and is associated with a high risk of disability. Objectives We describe a series of patients diagnosed with MS in […]